Evgen Pharma PLC (DE:8EV)
FRANKFURT:8EV
| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 396.00K | £ 442.00K | £ 0.00 | £ 194.00K |
| Gross Profit | £ -2.11M | £ 385.00K | £ 429.00K | £ -16.00K | £ -3.19M |
| Operating Income | £ -2.12M | £ -3.56M | £ -5.07M | £ -3.19M | £ -3.20M |
| EBITDA | £ -2.06M | £ -3.55M | £ -4.99M | £ -3.15M | £ -3.19M |
| Net Income | £ -1.94M | £ -3.14M | £ -4.04M | £ -2.73M | £ -2.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 4.11M | £ 2.00M | £ 5.00M | £ 9.03M | £ 11.59M |
| Total Assets | £ 7.63M | £ 3.06M | £ 6.17M | £ 9.64M | £ 12.42M |
| Total Debt | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Net Debt | £ -2.11M | £ -2.00M | £ -5.00M | £ -4.51M | £ -5.59M |
| Total Liabilities | £ 1.66M | £ 721.00K | £ 833.00K | £ 411.00K | £ 607.00K |
| Stockholders' Equity | £ 5.97M | £ 2.34M | £ 5.34M | £ 9.23M | £ 11.81M |
| Cash Flow | |||||
| Free Cash Flow | £ -2.37M | £ -3.00M | £ -4.03M | £ -2.56M | £ -2.93M |
| Operating Cash Flow | £ -2.37M | £ -3.00M | £ -4.03M | £ -2.56M | £ -2.93M |
| Investing Cash Flow | £ -2.08M | £ 0.00 | £ 4.52M | £ 1.48M | £ -6.00M |
| Financing Cash Flow | £ 4.55M | £ 0.00 | £ 0.00 | £ 0.00 | £ 10.39M |